Results 111 to 120 of about 18,495 (202)

Defensive medicine in dermatological practice – Dermatopathology as a mirror of structural challenges

JDDG: Journal der Deutschen Dermatologischen Gesellschaft, Volume 24, Issue 3, Page 302-315, March 2026.
Summary Defensive medicine refers to diagnostic or therapeutic actions taken primarily to reduce legal liability rather than to benefit the patient. In dermatopathology, defensive practices manifest in frequent immunohistochemical testing, overly cautious report phrasing, and reliance on multidisciplinary tumor boards.
Cornelia Sigrid Lissi Müller, Torsten Hansen, Claus Renzelmann   +2 more
wiley   +1 more source

Merkel cell carcinoma - particularities and morphological aspect of a unique and rare entity

Acta Marisiensis - Seria Medica
Introduction: Merkel cell carcinoma is a very rare malignant neoplasm which presents high aggressivity, high recurrence rate and has meta-static potential.
Tinca Andreea Cătălina, Lazar Bianca Andreea, Cotoi Ovidiu Simion   +2 more
doaj   +1 more source

RB1 inactivation in cutaneous carcinomas

Histopathology, Volume 88, Issue 4, Page 769-789, March 2026.
Among skin carcinomas, recurrent RB1 inactivation is observed in Merkel cell carcinoma, in a subset of squamous cell carcinoma with bowenoid morphology, in sebaceous carcinoma and in the recently described Wnt/beta‐catenin rosette‐forming carcinoma.
Tiffany Liv, Antoine Touzé, David Schrama, Serge Guyétant, Mahtab Samimi, Michael T Tetzlaff, Benjamin A Wood, Paul W Harms, Thibault Kervarrec   +8 more
wiley   +1 more source

Blue‐Gray Papules on the Chest and Face

JEADV Clinical Practice, Volume 5, Issue 1, Page 326-329, March 2026.
Sanjana Likki, Kevin Lee, Priyadharsini Nagarajan, Doina Ivan, Woo Cheal Cho, Fiorinda Muhaj   +5 more
wiley   +1 more source

The Influence of Extracellular Citrate in Physiological Concentration on the Proliferation of Malignant Melanoma

Journal of Cellular and Molecular Medicine, Volume 30, Issue 5, March 2026.
ABSTRACT Cancer cells rely on citrate for multiple metabolic processes, suggesting that limiting the availability of extracellular citrate may represent a novel therapeutic strategy. The plasma membrane citrate transporter (pmCiC) has been implicated in the pathogenesis of several cancers before, and its activity can be inhibited by gluconate.
Konstantin Drexler, Barbara Schwertner, Veronika Zenderowski, Laura Schreieder, Dennis Christoph Harrer, Mark Berneburg, Edward Geissler, Maria Mycielska, Sebastian Haferkamp   +8 more
wiley   +1 more source

Merkel Cell Carcinoma [PDF]

Ear, Nose & Throat Journal, 2014
Jeffrey D, Shiffer, Lester D, Thompson
openaire   +2 more sources

Merkel Cell Carcinoma: A Complete Response to Avelumab Immunotherapy. [PDF]

Clin Case Rep
Byrne E, Corbett M, Conlon E, O'Duffy F.
europepmc   +1 more source

Advanced Merkel cell carcinoma resulting in palliative amputation. [PDF]

JAAD Case Rep
Saito Y, Strong J, Bakayoko A, Yu J, Ng VY, Moresi JM.   +5 more
europepmc   +1 more source

A rare presentation of Merkel cell carcinoma in a young immunocompetent woman. [PDF]

JAAD Case Rep
Saka F, Kannan A, Das B, O'Leary MP, Fanucci LA, Chambers M, Lambrecht N, Gao L.   +7 more
europepmc   +1 more source

Tumor virus-induced lineage survival circuit drives Merkel cell carcinogenesis. [PDF]

J Clin Invest
Shuda M.
europepmc   +1 more source